May 17, 2017 Propanc News May 17, 2017/ LaunchpadIR Propanc Biopharma Awaits FDA Response to Orphan Drug Designation Request for Treatment of Pancreatic Cancer, as PRP Progresses to First-In-Human StudiesClick here to learn more.